Susquehanna Fundamental Investments LLC Invests $571,000 in National Health Investors, Inc. $NHI

Susquehanna Fundamental Investments LLC bought a new position in shares of National Health Investors, Inc. (NYSE:NHI) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 7,485 shares of the real estate investment trust’s stock, valued at approximately $571,000.

A number of other large investors have also recently bought and sold shares of NHI. International Assets Investment Management LLC acquired a new position in National Health Investors in the 4th quarter worth approximately $27,000. EverSource Wealth Advisors LLC lifted its stake in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares during the period. Garton & Associates Financial Advisors LLC purchased a new stake in shares of National Health Investors in the 4th quarter valued at $33,000. Allworth Financial LP purchased a new stake in shares of National Health Investors in the 2nd quarter valued at $42,000. Finally, Advisory Services Network LLC acquired a new stake in shares of National Health Investors in the third quarter worth $65,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Stock Performance

NHI opened at $71.70 on Thursday. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. The firm has a fifty day moving average price of $75.60 and a 200 day moving average price of $78.38. National Health Investors, Inc. has a 1 year low of $67.94 and a 1 year high of $91.38. The stock has a market cap of $3.52 billion, a P/E ratio of 20.72, a P/E/G ratio of 3.84 and a beta of 0.52.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The firm had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The business’s quarterly revenue was up 1.6% on a year-over-year basis. During the same period last year, the company posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities research analysts anticipate that National Health Investors, Inc. will post 4.78 earnings per share for the current year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.1%. National Health Investors’s dividend payout ratio (DPR) is currently 106.36%.

Insider Buying and Selling at National Health Investors

In related news, Director Robert A. Mccabe, Jr. bought 890 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were acquired at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the purchase, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

NHI has been the subject of several recent research reports. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Deutsche Bank Aktiengesellschaft cut their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research report on Thursday, June 25th. Truist Financial reduced their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday. BMO Capital Markets decreased their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a report on Monday, June 15th. Finally, Wells Fargo & Company lowered their target price on National Health Investors from $79.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, National Health Investors currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.57.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.